- Diagnosis is as per KDIGO criteria for standard AKI
Limitations of conventional markers
- Creatinine:
- Influenced by muscle mass and dietary protein intake, both of which vary perioperatively
- Does not begin to rise until GFR is <50% of normal
- This delay is lengthened further by renal functional reserve, i.e. compensatory hyperfiltration
- Urine output:
- Affected by fluid balance and diuretic use
- Loses diagnostic value when clinicians intervene in response to oliguria
- Cystatin C
- Less dependent on muscle mass and diet
- Rises rapidly with the onset of AKI
- More expensive and less widely available
Novel biomarkers
- Novel biomarkers aim to detect kidney injury earlier than creatinine, allowing earlier intervention
| Biomarker | Key points | Limitations |
| TIMP-2 × IGFBP7 ('NephroCheck') |
Urinary cell-cycle arrest proteins from proximal tubular cells First biomarkers available for clinical use Predicts AKI as early as 4h post-op |
Expensive Not specific to cause of injury Inversely correlated with urine output, so dilute urine may underestimate injury |
| NGAL | Released by damaged tubular cells Rises quickly, peaking ~6h post-op |
Not kidney specific (also lung, liver) Raised in inflammation, infection and CKD |
| KIM-1 | Proximal tubular protein upregulated after ischaemia-reperfusion injury | Slower rise and lower accuracy Expensive Mainly a research tool |
| DKK3 | Pre-operative urinary level predicts post-op AKI May identify those at risk of progression to CKD |
Research only Limited validation |
Other techniques under investigation
- Renal functional reserve: the rise in GFR in response to an IV amino acid load; lower in patients who go on to develop AKI
- Bladder urine oxygen tension: a surrogate for renal medullary oxygenation; lower intra-operatively in those who develop AKI, but unreliable in anuria
- Renal resistive index: measured with TOE; a raised index is associated with higher AKI incidence